A 40-Year-Old Man With Tricuspid Atresia, Status Post-Fontan, With Severe COVID-19 Pneumonia and Pneumothorax

Sumeet S Vaikunth; Michael R Bykhovsky; Anitra W Romfh; Christiane L Haeffele; Ian S Rogers; Emily Dong; Caroline Scribner; George K Lui

doi:10.1016/j.jaccas.2020.10.032

A 40-Year-Old Man With Tricuspid Atresia, Status Post-Fontan, With Severe COVID-19 Pneumonia and Pneumothorax

JACC Case Rep. 2021 Feb;3(2):187-191. doi: 10.1016/j.jaccas.2020.10.032. Epub 2021 Feb 3.

Authors

Sumeet S Vaikunth¹, Michael R Bykhovsky¹, Anitra W Romfh^{1

2}, Christiane L Haeffele^{1

2}, Ian S Rogers^{1

2}, Emily Dong^{1

2}, Caroline Scribner^{1

2}, George K Lui^{1

2}

Affiliations

¹ Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
² Department of Pediatrics, Division of Pediatric Cardiology, Stanford University School of Medicine, Palo Alto, California, USA.

Abstract

We report a case of COVID-19 in an adult single-ventricle patient post-Fontan-to our knowledge, the first report in this population documenting the use of the latest management recommendations for this novel disease. Additionally, this patient had significant pre-existing ventricular dysfunction, valvular disease, and comorbidities including HIV. (Level of Difficulty: Advanced.).

Keywords: ART, antiretroviral therapy; COVID-19, coronavirus disease-2019; HFNC, high-flow nasal cannula; PVR, pulmonary vascular resistance; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2; anticoagulation; congenital heart defect; pulmonary circulation.

Publication types

Case Reports